Orbio Corporation
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
Aug 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jun 17, 2027The maintenance fee for Glucose derivative, and cell imaging method and imaging agent using said derivative (US 10,509,041) comes due Jun 17, 2027. Unpaid by Dec 17, 2027, it lapses early.
- 1 fee due Aug 4, 2027The maintenance fee for Cancer cell detection method using living body-derived cells (US 10,551,387) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,958,450 | L-glucose derivatives having fluorescent chromophore In force · From the USPTO record | In force | From the USPTO record | |
| US 8,986,656 | Method for Evaluating Specific Incorporation of D-Glucose into Cells In force · High confidence | In force | High confidence | |
| US 10,288,604 | Method for Imaging Cell Using Fluorescence-Labeled Sugar Derivative Having Coumarin Derivative Bound Thereto, and Imaging Agent In force · High confidence | In force | High confidence | |
| US 10,509,041 | Glucose derivative, and cell imaging method and imaging agent using said derivative In force · From the USPTO record | In force | From the USPTO record | |
| US 10,001,487 | Glucose derivative, and cell imaging method and imaging agent using said derivative In force · From the USPTO record | In force | From the USPTO record | |
| US 10,551,387 | Cancer cell detection method using living body-derived cells In force · From the USPTO record | In force | From the USPTO record | |
| US 10,921,256 | Multi-surface image acquisition system, observation device, observation method, screening method, and stereoscopic reconstruction method of subject In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending